About us

OUR COMPANY

SOPHiA GENETICS is a health tech company democratizing Data-Driven Medicine to improve health outcomes and economics worldwide. By unlocking the power of new-generation health data for cancer and rare diseases management, the universal SOPHiA DDM Platform allows clinical researchers to act with precision and confidence. The company’s innovative approach enables an ever-expanding community of over 1,000 institutions to benefit from knowledge sharing, fostering a new era in healthcare. SOPHiA GENETICS achievement is recognized by the MIT Technology Review’s “50 Smartest Companies”.

Please visit us at https://www.sophiagenetics.com for more information about the company.



What they say
about Alamut

"We are very pleased with Alamut since it conveniently streamlines post-sequencing analyses of detected variants. We value the programme user friendliness and its all-in one approach to variant analysis."

PROF. MILAN MACEK Jr. M.D. Ph.D.
Charles University, Prague